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SObjective: In the current era, giant paraesophageal hernia repair by experienced minimally invasive surgeons
has excellent perioperative outcomes when performed electively. However, nonelective repair is associated
with significantly greater morbidity and mortality, even when performed laparoscopically. We hypothesized
that clinical prediction tools using pretreatment variables could be developed that would predict patient-
specific risk of postoperative morbidity and mortality.
Methods:We assessed 980 patients who underwent giant paraesophageal hernia repair (1997-2010; 80% elec-
tive and 97% laparoscopic). We assessed the association between clinical predictor covariates, including demo-
graphics, comorbidity, and urgency of operation, and risk for in-hospital or 30-day mortality and major
morbidity. By using forward stepwise logistic regression, clinical prediction models for mortality and major
morbidity were developed.
Results:Urgency of operation was a significant predictor of mortality (elective 1.1% [9/778] vs nonelective 8%
[16/199]; P<.001) and major morbidity (elective 18% [143/781] vs nonelective 41% [81/199]; P<.001). The
most common adverse outcomes were pulmonary complications (n ¼ 199; 20%). A 4-covariate prediction
model consisting of age 80 years or more, urgency of operation, and 2 Charlson comorbidity index variables
(congestive heart failure and pulmonary disease) provided discriminatory accuracy for postoperative mortality
of 88%. A 5-covariate model (sex, age by decade, urgency of operation, congestive heart failure, and pulmonary
disease) for major postoperative morbidity was 68% predictive.
Conclusions: Predictive models using pretreatment patient characteristics can accurately predict mortality and
major morbidity after giant paraesophageal hernia repair. After prospective validation, these models could pro-
vide patient-specific risk prediction, tailored for individual patient characteristics, and contribute to decision-
making regarding surgical intervention. (J Thorac Cardiovasc Surg 2013;145:721-9)Giant paraesophageal hernias (GPEHs) can be asymptom-
atic, cause chronic low-grade symptoms, or present acutely.
Chronic GPEH-related symptoms, such as heartburn, chest
discomfort, and dyspnea, are clear indications for surgical
repair, which can be approached laparoscopically with
acceptably low rates of mortality and morbidity when per-
formed electively.1-4 Quality of life after laparoscopic
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The Journal of Thoracic and Caregurgitation, and dyspnea symptoms in the majority of
patients. Preoperative pulmonary function abnormalities
and anemia are also improved after GPEH repair.5-9 The
improved perioperative mortality and morbidity
associated with elective laparoscopic GPEH repair has
prompted ongoing debate regarding the appropriate
timing for repair and the safety of watchful waiting.10-12
Proponents of watchful waiting cite evidence that the
historical risks, including high mortality and morbidity
associated with gastric volvulus and strangulation, are
overestimated.13 However, multiple retrospective reports
have shown that mortality and major morbidity associated
with nonelective GPEH repair was significantly higher
than after elective GPEH repair.14,15 Clearly, the ability to
weigh potential risks and benefits of operative
intervention would be extremely useful in guiding
treatment decisions.
Clinical prediction rules allow clinicians to determine the
probability of an outcome using existing clinical covariates,
either for their own decision-making or in counseling
patients.16 For example, the Pneumonia Severity Index,
developed to determine allocation of care in the treatment
of community-acquired pneumonia, uses clinical variables
obtained at emergency department presentation to assignrdiovascular Surgery c Volume 145, Number 3 721
Abbreviations and Acronyms
CCI ¼ Charlson comorbidity index
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San index risk score.17 The patient’s score guides clinical
decisions regarding hospital admission and oral versus
intravenous antibiotics. Similar clinical prediction rules to
assign risk categories for mortality and major morbidity af-
ter GPEH repair could inform provider decisions regarding
surgical intervention.
We hypothesized that clinical risk-stratification tools
based on known preoperative covariates could provide
patient-specific perioperative mortality and major morbid-
ity estimates in the preoperative setting. The aim of this
study was to develop easy-to-use clinical prediction rules,
incorporating readily available preoperative covariates
that have discriminatory accuracy for predicting patient
risk for perioperative mortality and major morbidity after
laparoscopic repair of GPEH.
MATERIALS AND METHODS
Patient Selection
Adult patients (n ¼ 980) who underwent primary transabdominal (lap-
aroscopic or open) repair of GPEH (January 1, 1997, to August 31, 2010)
were retrospectively identified from a prospectively maintained database.
GPEH was defined as more than 30% gastric herniation into the posterior
mediastinum.18 Patients undergoing elective (n¼ 781; 80%) and nonelec-
tive surgery were included. Nonelective surgery was defined as urgent
(n ¼ 173; patient requiring admission for GPEH symptom management
and repaired during the same admission) or emergency (n¼ 26; immediate
operation in patient with acute GPEH-related complications). Patients with
prior antireflux surgery or GPEH repair were excluded. This study was ap-
proved by our institutional review board (Pittsburgh, Pa).
Operative Approach
A laparoscopic approach was planned in 951 patients (97%). Our ap-
proach to laparoscopic GPEH repair has been described.1,19 Hernia
reduction, extensive esophageal mobilization, and crural reapproximation
were performed in all patients. Definitive GPEH repair, with an
antireflux procedure to minimize postoperative reflux, was performed in
888 patients (91%). Fundoplication was partial (Toupet or Dor) in 206
patients and circumferential (Nissen) in the remaining 682 patients. Of
the 888 patients treated with fundoplication, a Collis gastroplasty for
esophageal lengthening was added in 465 patients (52%). Mesh repair
was performed in 116 patients (12%). Patients who received GPEH
repair without fundoplication were also included (n ¼ 92 [9%]; eg,
gastropexy, Roux-en-Y near-esophagojejunostomy, and gastroesophageal
resection). Type of fundoplication and the need for mesh cruroplasty or
esophageal lengthening were determined intraoperatively. GPEH repairs
were performed by 19 surgeons over the time period of study with 498
(51%) performed by the senior surgeon (JDL).
Data Collection and Outcome Measures
Identification of predictor covariates. Predictor variables
were defined as patient demographics, symptoms, covariates defined by
the Charlson comorbidity index (CCI),20 urgency of operation, and722 The Journal of Thoracic and Cardiovascular Surglaboratory and radiographic findings that were known when the decision
for surgery was made. Covariates in the CCI that were present in less
than 3% of patients were grouped together as 1 variable (rare CCI condi-
tions). These included diabetesmellitus with organ damage, peripheral vas-
cular disease, renal disease, liver disease, hemiplegia or paraplegia,
lymphoma, leukemia, metastatic cancer, and acquired immunodeficiency
syndrome.
Definition of outcome variables. Postoperative adverse out-
comes, including hospital or 30-day mortality and major morbidity, were
assessed using the Society of Thoracic Surgeons’ definitions for postoper-
ative complications.21 A binary outcome for mortality was defined as death
during the initial hospital stay or within 30 days after surgery, whichever
was longer. Likewise, a binary outcome measure for major morbidity
was defined as at least 1 major adverse event during the initial hospital
stay or within 30 days after surgery, whichever was longer, and included
pneumonia, reintubation, tracheostomy, pulmonary embolism, myocardial
infarction, congestive heart failure, acute renal failure, cerebral vascular
accident, septic shock or bacteremia, postoperative gastric or esophageal
leak, perioperative hernia recurrence, and readmission or reoperation
within 30 days. Mortality data were missing for 3 patients who survived
to discharge in less than 30 days but were subsequently lost to follow-up.
Therefore, a total of 977 patients were assessed for predictors of mortality,
and 980 patients were assessed for predictors of major morbidity.
Statistical Analysis and Development of Clinical
Prediction Rules
Descriptive statistics were summarized with frequencies and percent-
ages for categoric variables, and median with interquartile range (IQR)
for continuous variables. The Fisher exact test and Student t test were
used to compare differences between groups. Predictive models for mortal-
ity and major morbidity were then derived using forward, stepwise logistic
regression. The performance of each predictive model was then estimated
using bootstrap leave-one-out cross-validation analysis. Statistical analysis
was performed using IBM SPSS 19 (IBM Corp, Armonk, NY) and STATA
SE 11.0 (StataCorp LP, College Station, Tex) software.
Because the number of patients with postoperative mortality was small
(n ¼ 25), and thus limited the number of potential predictors that could
be assessed, an a priori ‘‘P value for inclusion’’ of .05 was chosen to
indicate a statistically significant change in the model at each step in
the regression. In addition, because urgency of operation is well estab-
lished as a clinically important predictor of adverse outcome after
GPEH repair, we began regression modeling for mortality by forcing
the urgency variable into the model as the first covariate and then began
forward, stepwise regression from that point. At each step, 1 additional
variable was assessed using logistic regression; if the addition of that var-
iable produced a significant change (P ¼ .05 or less) in the predictive ac-
curacy of the model, that variable was included and the next step was
performed by re-running the logistic regression with the next variable.
This process continued until no more variables could be added, and at
that point, the model was considered final. Variable inclusion order de-
pended on the variable that caused the most significant model change,
that is, the smallest P value for that step.
An identical process was performed for the major morbidity prediction
model; however, because the number of patients experiencing major mor-
bidity was large (n¼ 224), an a priori P value of .15 was selected as the ‘‘P
value for inclusion’’ cutoff. This number of events allowed us to assess up
to 22 variables in the model, enabling a larger P value for inclusion and re-
ducing the chance that important predictors would be overlooked.
Of 980 patients, 26 (2.7%) were excluded from the regression analyses
for mortality and 23 (2.3%) were excluded from the regression analyses for
morbidity because of 1 or more missing predictor variables in any of the
potential predictors considered in the model. We also excluded peptic ulcer
disease, a CCI variable, from the mortality model because of inconsistency
in the documentation of peptic ulcer disease in the medical record.ery c March 2013
Ballian et al General Thoracic Surgery
G
T
STo determine the discriminatory accuracy of the predictive model, the
area under the receiver operating characteristic curve was determined for
each outcome model. Risk scores for mortality and major morbidity
were then calculated. By using the same method developed to assign risk
score in the CCI,20 a risk score for each covariate in the model was deter-
mined by assessing the odds ratio and assigning a whole number points
value. As was done in the original description of the CCI, for odds ratios
1.2 or greater and less than 1.5, 1 point was assigned; for odds ratios 1.5
or greater and less than 2.5, 2 points were assigned; for odds ratios 2.5
or greater and less than 3.5, 3 points were assigned and so on. Categories
were then created on the basis of the risk score with 3 groups for the mor-
tality risk model and 4 groups for the major morbidity risk model. The rate
of mortality and major morbidity for each group was determined.
RESULTS
The majority of patients were female (n ¼ 733; 75%)
with a median age of 71 years (IQR, 62-78 years). The me-
dian body mass index was 29 kg/m2 (IQR, 26-33). At least
50% of the stomach was herniated into the mediastinum
in 82% of patients and 24% had a completely intrathoracic
stomach (Table 1). At least 1 preoperative CCI comorbidity
was present in 60% of patients (n¼ 592). Themost common
comorbid condition was pulmonary disease. The most com-
mon preoperative symptoms were respiratory problems
(dyspnea, recurrent pneumonia, or aspiration), chest or ab-
dominal pain, heartburn, and regurgitation (Table 1).
Predictors of Mortality and Major Morbidity
In-hospital or 30-day mortality occurred in 2.6% of
patients (n¼ 25). Mortality was 1.1% after elective surgery
and 8.0% after nonelective surgery (P<.01). Additional fac-
tors associated with mortality included older age at opera-
tion, lower body mass index, history of congestive heart
failure, cerebral vascular accident, dementia, pulmonary dis-
ease, peptic ulcer disease, and malignancy within the past 5
years. There was a trend toward increased mortality in pa-
tients with regurgitation as a presenting symptom (Table 1).
At least 1 major morbidity was identified in 22.9% of pa-
tients (n ¼ 224). Older age at operation, lower body mass
index, and larger preoperative hernia were significantly as-
sociated with an increased rate of major postoperative mor-
bidity (Table 1). CCI variables associated with major
postoperative morbidity include history of myocardial in-
farction or coronary revascularization, congestive heart fail-
ure, cerebral vascular accident or transient ischemic attack,
dementia, and pulmonary disease (Table 1). The only preop-
erative symptom that was significantly associated with ad-
verse outcome was heartburn, which was less likely to be
present in patients who had at least 1 adverse event (Table
1). Patients with preoperative heartburn were also younger
(P<.001), more likely to have smaller hernia (P<.001),
and less likely to have urgent operation (P<.001).
Development of the Clinical Prediction Rule
Forward stepwise logistic regression was performed to
identify combinations of variables most predictive ofThe Journal of Thoracic and Capostoperative mortality and major morbidity. For postoper-
ative mortality, a 4-variable model consisting of 2 CCI vari-
ables (history of congestive heart failure and history of
pulmonary disease), age at operation (80 vs<80 years),
and urgency of operation (Table 2; risk score range, 0-20)
predicted mortality with discriminatory accuracy of
88.4% (95% confidence interval, 82.0-94.8). Patients
were then categorized into groups on the basis of the mor-
tality risk score. Low-risk (mortality risk score, 0-2),
intermediate-risk (mortality risk score 3), and high-risk
(mortality risk score, 4þ) categories were associated with
increasing risk for postoperative mortality (Figure 1).
For postoperative morbidity, a 5-variable model consist-
ing of sex, age at operation (by decade), history of conges-
tive heart failure, history of pulmonary disease, and urgency
of operation (Table 2; risk score range, 0-12) predicted ma-
jor morbidity with discriminatory accuracy of 67.8% (area
under the receiver operating characteristic curve, 0.678;
95% confidence interval, 0.637-0.718). When risk score
was categorized into minimal, low, intermediate, and high
risk, increasing risk category was associated with increas-
ing incidence of at least 1 major adverse outcome. For pa-
tients in the minimal risk category (morbidity risk score
0-2), at least 1 major adverse outcome was identified in
13.5% compared with a rate of 40.6% in the patients in
the high-risk category (morbidity risk score 5þ). Increasing
risk category was also associated with progressively in-
creasing rates of most of the major adverse outcomes as-
sessed in the study (Table 3).
To assess how the models developed for major adverse
outcome and postoperative mortality might generalize to
an independent data set, we performed leave-one-out boot-
strap cross-validation. The leave-one-out cross validation
error rate was 21.503% for any major adverse outcome
and 2.304% for postoperative mortality. These are nearly
identical to the 21.399% and 2.304% error rates from the
fitted models, indicating that application of the models to
new patient data sets would yield similar results.
Factors Associated With Nonelective Operation
Because nonelective operation was a significant, inde-
pendent predictor of mortality and major morbidity in our
models, we assessed the clinical covariates associated
with urgent or emergency GPEH repair (Table 4). Patients
undergoing nonelective operation were more likely to be
male, to be in the 70þ-year age groups, to be underweight
or ideal body weight, and to have larger hernia. Charlson
comorbid diseases were more common in patients who un-
derwent nonelective repair. Symptoms that were more com-
monly present in patients who underwent nonelective repair
included respiratory symptoms, chest or abdominal pain,
heartburn, regurgitation, and bloating. Age 80 years or
more at operation, preoperative hernia size of 75% or
greater, and a history of dementia or peptic ulcer diseaserdiovascular Surgery c Volume 145, Number 3 723
TABLE 1. Association of patient demographics, comorbid diseases, and symptoms with major adverse outcome and mortality after giant
paraesophageal hernia repair
Patient demographics: n (%)
Overall
Major adverse outcome
P value
30-d mortality
No Yes Alive Dead
P valuen ¼ 980 n ¼ 756 n ¼ 224 n ¼ 952 n ¼ 25
Sex Female 733 (75) 574 (78) 159 (22) .137 713 (78) 18 (2) .815
Male 247 (25) 182 (74) 65 (26) 239 (97) 7 (3)
Age group at operation <50 y 60 (6) 53 (88) 7 (12) <.001 59 (98.3) 1 (1.7) <.001
50-59 y 148 (15) 124 (84) 24 (16) 147 (100) 0 (0)
60-69 y 261 (27) 212 (81) 49 (19) 260 (99.6) 1 (0.4)
70-79 y 319 (32) 245 (77) 74 (23) 315 (98.7) 4 (1.3)
80 y 192 (20) 122 (64) 70 (36) 171 (90) 19 (10)
BMI by WHO classification* Underweight 16 (2) 10 (63) 6 (37) .042 14 (87.5) 2 (12.5) .001
Ideal 185 (19) 131 (71) 54 (29) 175 (94.6) 10 (5.4)
Overweight 356 (37) 281 (79) 75 (21) 345 (97.7) 8 (2.3)
Obese 258 (27) 210 (81) 48 (19) 257 (99.6) 1 (0.4)
Severely obese 149 (15) 119 (80) 30 (20) 148 (99.3) 1 (0.7)
Preoperative hernia size (%)y 30%-49% 174 (18) 146 (84) 28 (16) .009 169 (97.1) 5 (2.9) .171
50%-74% 354 (36) 276 (78) 78 (22) 345 (97.7) 8 (2.3)
75%-99% 212 (22) 166 (78) 46 (22) 210 (99.1) 2 (0.9)
Intrathoracic Stomach 240 (24) 168 (70) 72 (30) 228 (95.8) 10 (4.2)
History of pretreatment Charlson-defined patient comorbidity
Myocardial infarction or revascularization No 833 (85) 653 (78) 180 (22) .033 812 (97.6) 20 (2.4) .402
Yes 147 (15) 103 (70) 44 (30) 140 (96.5) 5 (3.5)
Congestive heart failure No 941 (96) 741 (79) 200 (21) <.001 918 (97.9) 20 (2.1) .002
Yes 39 (4) 15 (38) 24 (62) 34 (87.2) 5 (12.8)
Cerebral vascular accident or transient attack No 904 (92) 708 (78) 196 (22) .004 882 (97.9) 19 (2.1) .010
Yes 76 (8) 48 (63) 28 (37) 70 (92.2) 6 (7.9)
Dementia No 937 (96) 732 (78) 205 (22) .001 917 (98.2) 17 (1.8) <.001
Yes 43 (4) 24 (56) 19 (44) 35 (81.4) 8 (18.6)
Pulmonary disease No 690 (70) 548 (79) 142 (21) .010 675 (98.3) 12 (1.8) .024
Yes 290 (30) 208 (72) 82 (28) 277 (95.5) 13 (4.5)
Connective tissue disorder No 942 (96) 728 (77) 214 (23) .560 916 (97.6) 23 (2.5) .253
Yes 38 (4) 28 (74) 10 (26) 36 (94.7) 2 (2.3)
Peptic ulcer disease No 794 (81) 617 (78) 177 (22) .384 777 (98.2) 14 (1.8) .003
Yes 186 (19) 139 (18) 47 (21) 175 (94.1) 11 (5.9)
Diabetes requiring medical therapy No 909 (93) 705 (78) 204 (22) .304 884 (97.6) 22 (2.4) .419
Yes 71 (7) 51 (72) 20 (28) 68 (95.8) 3 (4.2)
Malignancy in the past 5 y No 924 (94) 716 (77) 208 (23) .325 900 (97.7) 21 (2.3) .050
Yes 56 (6) 40 (71) 16 (29) 52 (92.9) 4 (7.1)
Rare CCI variablesz No 939 (96) 730 (78) 209 (22) .038 914 (97.7) 22 (2.4) .083
Yes 41 (4) 26 (63) 15 (37) 38 (92.7) 3 (7.3)
Preoperative symptoms
Respiratory symptoms No 232 (34) 183 (79) 49 (21) .443 223 (96.1) 9 (3.9) .341
Yes 450 (66) 342 (76) 108 (24) 436 (97.5) 11 (2.5)
Chest or abdominal pain No 273 (32) 221 (81) 52 (19) .081 266 (97.8) 6 (2.2) 1.000
Yes 589 (68) 444 (75) 145 (25) 574 (97.8) 13 (2.2)
Heartburn No 335 (35) 233 (70) 102 (30) <.001 323 (97) 10 (3) .365
Yes 626 (65) 513 (82) 113 (18) 613 (98.1) 12 (1.9)
Dysphagia No 533 (55) 406 (76) 127 (24) .353 519 (97.6) 13 (2.4) 1.000
Yes 431 (45) 340 (79) 91 (21) 418 (97.4) 11 (2.6)
Regurgitation No 377 (39) 286 (76) 91 (24) .345 370 (98.7) 5 (1.3) .061
Yes 590 (61) 463 (78) 127 (22) 569 (96.6) 20 (3.4)
Bloating No 619 (66) 476 (77) 143 (23) .411 602 (97.6) 15 (2.4) .649
Yes 325 (34) 258 (79) 67 (21) 318 (98.2) 6 (1.9)
BMI, Body mass index (kg/m2); WHO, World Health Organization; CCI, Charlson Comorbidity Index. *Underweight BMI<18.5, ideal BMI 18.5-25, overweight BMI 25-30,
obese BMI 30-35, severely obese BMI 35. BMI was available for 964 patients with 30-day mortality data for 961. yPercent of stomach within the mediastinum by barium
esophagram, preoperative endoscopy, or intraoperative description. zRare CCI variables (<3% of cohort) include peripheral vascular disease, renal disease, liver disease, diabetes
mellitus with organ damage, hemiplegia or paraplegia, lymphoma, leukemia, metastatic cancer, and acquired immunodeficiency syndrome.
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TABLE 2. Clinical prediction rules for in-hospital or 30-day mortality (A, mortality model) and major morbidity (B, morbidity model): Variables
included in predictive models after forward stepwise logistic regression analysis and points assigned for each risk factor present
Variables in each model Points Comparison P value Adjusted ORz 95% CI
A. Mortality
Congestive heart failure* 5 Present vs absent .009 4.740 1.481-15.172
Pulmonary disease* 3 Present vs absent .009 3.342 1.345-8.306
Surgery typey 3 Nonelective vs elective .021 3.165 1.193-8.397
Age 80 (y) 9 80 vs<80 <.001 8.577 3.043-24.174
B. Morbidity
Sex 1 Male vs female .122 1.328 0.927-1.901
Congestive heart failure* 4 Present vs absent <.001 4.267 2.083-8.737
Pulmonary disease* 2 Present vs absent .015 1.515 1.083-2.121
Surgery typey 2 Nonelective vs elective <.001 2.142 1.466-3.128
Age group (y)
1 50-59 vs<50 .395 1.487 0.596-3.712
2 60-69 vs<50 .221 1.718 0.722-4.086
2 70-79 vs<50 .128 1.940 0.826-4.558
3 80 vs<50 <.001 2.689 1.123-6.441
OR, Odds ratio; CI, confidence interval. *History of each comorbid disease as defined in the CCI. yNonelective surgery includes urgent and emergency surgery as defined by the
Society of Thoracic Surgeons. zAdjusted for all other factors in the model.
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variate analysis. Patients who had a nonelective operation
were also significantly more likely to have a planned open
repair (23/199; 12%) than patients who underwent elective
repair (6/781; 0.8% [P<.001]).DISCUSSION
By using known pretreatment covariates, we have devel-
oped clinical prediction rules for mortality and major mor-
bidity after GPEH repair that provide good discriminatory
accuracy and could be easily implemented in the clinical
setting. We found that the combination of nonelective oper-
ation, age 80 years or more, history of pulmonary disease,FIGURE 1. In-hospital or 30-day mortality. Patients were assigned points
according to the presence of risk factors for mortality. Increasing risk score
correlates with the incidence of mortality. Incidence of mortality (in bold)
and numbers of patients within each group are shown.
The Journal of Thoracic and Caand history of congestive heart failure clearly identified
a group of patients at increased risk for perioperative mor-
tality. By using these variables, our models also identified
a group of patients at very low risk for perioperative mortal-
ity. Likewise, our 5-covariate model for major morbidity,
including sex, age at operation, urgency of operation, his-
tory of congestive heart failure, and history of pulmonary
disease, facilitated assignment of patients into minimal-,
low-, intermediate-, and high-risk categories on the basis
of their pretreatment scores. Of note, the risk for perioper-
ative mortality more than tripled and the risk for major mor-
bidity more than doubled when nonelective repair was
required. Although a limited number of previous reports
have examined the association of preoperative variables to
adverse outcomes after GPEH repair,2,22 our study is the
first to develop prediction models for adverse outcome
based on pretreatment variables.
Impact of Nonelective Repair on Patient Risk
There is little debate that the risks of operative interven-
tion outweigh the benefits in completely asymptomatic pa-
tients with GPEH. In symptomatic patients, however, the
literature is somewhat conflicting. Historically, it has been
recommended that all patients with paraesophageal hernia
undergo repair at the time of diagnosis to prevent the cata-
strophic complications that can occur with acute mechani-
cal symptoms, including gastric strangulation, massive
hemorrhage, or perforation.13 More recently, however, it
was suggested that minimally symptomatic patients can
be managed expectantly.10 By usingMarkovmodeling, Sty-
lopoulos and colleagues10 created theoretic cohorts with
minimal symptoms and determined the outcomes for 2 ap-
proaches: immediate repair or watchful waiting. In their de-
cision analysis, the mortality difference between electiverdiovascular Surgery c Volume 145, Number 3 725
TABLE 3. Distribution of postoperative morbidity within categories of predicted risk
Postoperative outcome: n (%)
Total
Major morbidity risk score
P value
Minimal Low Intermediate High
0-2 3 4 5þ
n ¼ 980 n ¼ 407 n ¼ 173 n ¼ 188 n ¼ 212
At least 1 major adverse outcome 224 (23) 55 (13.5) 34 (19.7) 49 (26.1) 86 (40.6) <.001
Any pulmonary complication* 199 (20.3) 51 (12.5) 28 (16) 38 (20) 82 (39) <.001
Pneumonia 65 (6.7) 15 (3.7) 7 (4.1) 14 (7.5) 29 (13.8) <.001
Reintubation 42 (4.3) 7 (1.7) 3 (1.7) 11 (5.9) 21 (9.9) <.001
Postoperative tracheostomy 8 (0.8) 1 (0.25) 0 (0) 2 (1.1) 5 (2.4) .027
Pulmonary embolism 34 (3.5) 13 (3.2) 6 (3.5) 8 (4.3) 7 (3.3) .909
Myocardial infarction 11 (1.1) 3 (0.74) 0 (0) 1 (0.5) 7 (3.3) .012
Congestive heart failure 36 (3.7) 2 (0.5) 4 (2.3) 5 (2.7) 25 (11.9) <.001
Acute renal failure 25 (2.6) 0 (0) 3 (1.7) 3 (1.6) 19 (9) <.001
Cerebral vascular accident 6 (0.6) 1 (0.25) 0 (0) 1 (0.53) 4 (1.9) .068
Septic shock or bacteremia 21 (2.1) 2 (0.5) 3 (1.7) 7 (3.7) 9 (4.3) .003
Postoperative gastric or esophageal leak 21 (2.2) 6 (1.5) 2 (1.2) 7 (3.7) 6 (2.8) .229
Perioperative hernia recurrence 12 (1.2) 4 (1) 3 (1.7) 1 (0.5) 4 (1.9) .528
Readmission within 30 d of operation 96 (9.8) 21 (5.2) 16 (9.3) 22 (11.7) 37 (17.5) <.001
Reoperation within 30 d of operation 60 (6.1) 13 (3.2) 8 (4.7) 17 (9.0) 22 (10.4) .001
*Any pulmonary complication includes pneumonia, tracheostomy, unplanned bronchoscopy, pneumothorax or pleural effusion requiring drainage, reintubation, and prolonged
initial ventilation more than 48 hours.
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Sand emergency surgery was the only factor influencing the
value of elective surgery. They concluded that, assuming
a 17%mortality rate of emergency surgery, elective laparo-
scopic GPEH repair becomes the optimal management if
mortality with elective laparoscopic repair is less than
1%. If the mortality rate of emergency surgery is 6%,
a value close to the mortality rate of 8% seen in our series,
elective repair is recommended only if it can be achieved
with mortality of 0.5% or less.10
When considering whether to adopt the recommenda-
tions for watchful waiting into clinical practice, it is impor-
tant to note that the model developed by Stylopoulos and
colleagues10 was designed to establish mortality cutoffs
for minimally symptomatic patients. In this model, mini-
mally symptomatic was defined as patients with symptoms
(belching and heartburn) that do not affect the quality of life
of the patient.10 However, we and others have reported the
significant impact of GPEH on quality of life, even in pa-
tients whose primary symptom is heartburn.1,3,5,9,23-28 The
majority of patients, particularly those with larger hernias,
have mechanical symptoms such as pain, postprandial
bloating, and bleeding (acute and occult). Careful
assessment for symptoms frequently reveals symptoms of
chest and abdominal pain, postprandial bloating,
dysphagia, chronic anemia, weight loss, change in eating
habits, or food avoidance.6,7,9 In patients with any of
these symptoms, particularly when 75% or more of the
stomach is herniated into the mediastinum, careful
consideration for elective repair should be entertained.
In the current study, we found a strong independent asso-
ciation of nonelective repair with increased risk of mortality
and major morbidity after GPEH repair. This is consistent726 The Journal of Thoracic and Cardiovascular Surgwith many other reports in the literature; recently published
analyses of administrative datasets showmortality for emer-
gency repair ranges from 5.1% to 16.4%.10,12,15 It has also
been noted that the risk of nonelective repair increases
dramatically in the very elderly, as does the risk for
associated mortality. Poulose and colleagues14 assessed
the impact of nonelective repair on postoperative mortality
in octogenarians using the 2005 National Inpatient Sample;
they found that, similar to the results presented in our series,
43% of the octogenarians in the nationwide sample under-
went nonelective repair (47% in our series). Mortality after
nonelective repair in the nationwide sample was markedly
higher than for nonelective repair (16% for nonelective vs
2.4% for elective repair). We also found a marked increase
in mortality (14%) for nonelective repair in the octogenar-
ians compared with 6% for elective repair, although it did
not reach a statistical significance level because of the
smaller numbers of patients. Nonelective repair has also
been shown to be associated with longer hospital stay and
higher cost.12
Impact of Increasing Age, Comorbidity, and Hernia
Size at Time of Repair on Patient Risk
Despite the higher risk, age alone should not be a contra-
indication to elective laparoscopic repair in symptomatic
patients, because the majority of elderly patients do not
experience postoperative mortality or major morbid-
ity.2,11,15,22,27,29,30 In addition to age, a history of
congestive heart failure requiring medical therapy and
a history of pulmonary disease are predictors of adverse
outcome after GPEH repair. Although none of the
electively repaired patients in this current study hadery c March 2013
TABLE 4. Association of patient demographics, comorbid diseases, and symptoms with urgent or emergency paraesophageal hernia repair
Patient demographics: n (%)
Overall
Nonelective operation
P value Adjusted ORx 95% CI
Elective Nonelective
n ¼ 980 n ¼ 781 n ¼ 199
Sex Female 733 (75) 595 (81) 138 (19) .055
Male 247 (25) 186 (75) 61 (25)
Age group at operation <50 y 60 (6) 51 (85) 9 (15) <.001 ref ref
50-59 y 148 (15) 130 (88) 18 (12) 0.80 (0.33-1.96)
60-69 y 261 (27) 234 (90) 27 (10) 0.61 (0.26-1.42)
70-79 y 319 (33) 265 (83) 55 (17) 0.93 (0.42-2.09)
80 y 192 (20) 102 (53) 90 (47) 2.66 (1.16-6.10)
BMI by WHO classification* Underweight 16 (2) 9 (56) 7 (44) <.001 ref ref
Ideal 185 (19) 126 (68) 59 (32) 0.50 (0.13-1.73)
Overweight 356 (37) 295 (83) 61 (17) 0.35 (0.10-1.12)
Obese 258 (27) 220 (85) 38 (15) 0.36 (0.10-1.27)
Severely obese 149 (15) 127 (85) 22 (15) 0.42 (0.12-1.54)
Preoperative hernia size (%)y 30%-49% 174 (18) 157 (90) 17 (10) <.001 ref ref
50%-74% 354 (36) 300 (85) 54 (15) 1.40 (0.74-2.60)
75%-99% 212 (22) 159 (75) 53 (25) 2.60 (1.25-4.88)
Intrathoracic stomach 240 (24) 165 (69) 75 (31) 3.00 (1.59-5.58)
History of pretreatment Charlson-defined patient comorbidity
Myocardial infarction or revascularization No 833 (85) 677 (81) 156 (19) .005 1.27 (0.80-2.02)
Yes 147 (15) 104 (71) 43 (29)
Congestive heart failure No 941 (96) 761 (81) 180 (19) <.001 1.84 (0.83-4.05)
Yes 39 (4) 20 (51) 19 (48)
Cerebral vascular accident or transient attack No 904 (92) 737 (82) 167 (18) <.001 1.60 (0.87-2.83)
Yes 76 (8) 44 (58) 32 (42)
Dementia No 937 (96) 763 (81) 174 (19) <.001 2.43 (1.13-5.22)
Yes 43 (4) 18 (42) 25 (58)
Pulmonary disease No 690 (70) 550 (80) 140 (20) 1.000
Yes 290 (30) 231 (80) 59 (20)
Connective tissue disorder No 942 (96) 750 (80) 192 (20) 1.000
Yes 38 (4) 31 (82) 7 (18)
Peptic ulcer disease No 794 (81) 655 (82) 139 (18) <.001 2.20 (1.50-3.30)
Yes 186 (19) 126 (68) 60 (32)
Diabetes requiring medical therapy No 909 (93) 728 (80) 181 (20) .284
Yes 71 (7) 53 (75) 18 (25)
Malignancy in the past 5 y No 924 (94) 740 (80) 184 (20) .231
Yes 56 (6) 41 (73) 15 (27)
Rare CCI variablesz No 939 (96) 753 (80) 186 (20) .074
Yes 41 (4) 28 (68) 13 (32)
Preoperative symptoms
Respiratory symptoms No 232 (34) 164 (71) 68 (29) <.001
Yes 450 (66) 373 (83) 77 (17)
Chest or abdominal pain No 273 (32) 236 (86) 37 (14) .001
Yes 589 (68) 449 (76) 140 (24)
Heartburn No 335 (35) 226 (67) 109 (33) <.001
Yes 626 (65) 545 (87) 81 (13)
Dysphagia No 533 (55) 418 (78) 115 (22) .122
Yes 431 (45) 356 (83) 75 (17)
Regurgitation No 377 (39) 316 (84) 61 (16) .014
Yes 590 (61) 456 (77) 134 (23)
Bloating No 619 (66) 483 (78) 136 (22) .016
Yes 325 (34) 275 (85) 50 (15)
OR, Odds ratio; CI, confidence interval; BMI, body mass index (kg/m2);WHO,World Health Organization; CCI, Charlson Comorbidity Index. *Underweight BMI<18.5, ideal
BMI 18.5-25, overweight BMI 25-30, obese BMI 30-35, severely obese BMI35. yPercent of stomach within the mediastinum by barium esophagram, preoperative endoscopy,
or intraoperative description. zRare CCI variables (<3% of cohort) include peripheral vascular disease, renal disease, liver disease, diabetes mellitus with organ damage, hemi-
plegia or paraplegia, lymphoma, leukemia, metastatic cancer, and acquired immunodeficiency syndrome. xEach adjusted for the other variables in the model (age group, BMI,
size of hernia, myocardial infarction, congestive heart failure, cerebral vascular accident or transient attack, dementia, and peptic ulcer disease).
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increased risk for adverse outcome associated with these
comorbid conditions would allow for medical
optimization before elective surgery for symptomatic
GPEH. Recognition of the increased risk may also inform
the decision to forego surgical repair altogether if the
hernia is small, the patient is very elderly with other
comorbid conditions, and the symptoms are
predominantly regurgitation related rather than obstructive.
To address these risk factors, our current approach to pa-
tients with GPEH is routine cardiac testing on the majority
of patients before elective and urgent repair if the patient’s
clinical status will allow. This is because the majority of pa-
tients are elderly and have a history of smoking or obesity or
other cardiac risk factors, such as family history, personal
history of cardiac disease, hypertension, hyperlipidemia,
or diabetes mellitus. In addition, chest pain is often one of
the primary symptoms. Although the chest pain is often
due to the GPEH itself, there are occasional patients in
whom concomitant coronary artery disease is identified.
For those patients in whom repair is elective and coronary
disease is identified, optimization with medical or invasive
techniques is performed before GPEH repair. It is important
to note that all patients who are under the management of
a cardiologist are sent to their provider for preoperative
optimization and clearance. Pulmonary function testing is
obtained on any patients with pulmonary symptoms, and
smoking cessation is strongly encouraged for current
smokers. This proactive approach likely reduces postopera-
tive mortality and major morbidity and improves outcomes
for these patients.
The clinical prediction rules presented may provide
a more accurate understanding of patient-specific risk for
adverse outcomes with elective repair at an earlier age com-
pared with the risk of nonelective repair when older if
watchful waiting is undertaken. For example, a 65-year-
old woman with pulmonary disease and GPEH would
have a risk score for mortality of 3 (mortality rate, 0.7%)
if the operation was performed electively and a risk score
of 6 (mortality rate, 9.3%) if performed nonelectively.
With regard to major postoperative morbidity, the patient’s
current risk category for elective repair is intermediate (risk
score 4 for age and pulmonary disease). Waiting for acute
presentation and nonelective repair increases the risk cate-
gory for major morbidity to high risk (40%). Given an es-
timated lifetime risk of developing acute symptoms of
18% and an estimated annual probability of symptom pro-
gression of approximately 14%,10 elective repair would be
warranted, preferably before the patient reaches 80 years of
age, when perioperative mortality increases steeply.
Although paraesophageal hernia size did not remain in
the final model because of high collinearity with age and
nonelective operation, it is important to note that the risk
of nonelective operation did increase with increased hernia728 The Journal of Thoracic and Cardiovascular Surgsize. Combined with the other high-risk criteria in the clin-
ical prediction models, waiting for an acute presentation in
a patient with the majority of stomach herniated into the
mediastinum could prove fatal. On the other hand, a patient
with other high-risk criteria and a small GPEH may be ad-
vised to pursue medical therapy, especially if the symptoms
are predominantly heartburn.
Study Strengths and Limitations
Our study has several strengths and limitations. With the
large numbers of patients in our extensive, prospectively
maintained database for GPEH, and definition-driven ab-
straction of covariates, we are uniquely positioned to de-
velop these clinical predication rules. However, our study
findings may be limited by the fact that the overall mortality
in our series was low and restricted our ability to identify
additional predictors of mortality, such as stratifying risk
by expanded age groups. Thus, our model may have over-
looked other important predictors. Our findings may be
hard to generalize because our center has extensive exper-
tise in the management of GPEH and the majority of both
elective and nonelective repairs were performed laparos-
copically. It is possible that open repair is a significant pre-
dictor of adverse outcome after GPEH repair; this could not
be assessed in our series because of the significant collinear-
ity between nonelective repair and a planned open approach
to operation. As a result, the rate of adverse outcomes in our
series may not represent the observed rates in other centers.
Ideally, our model would have also undergone external
validation; however, we were able to perform internal
cross-validation bootstrapping using the leave-one-out
strategy, which showed error rates that were similar to the
rates for the developed models for both outcomes. Further
validation of the models in other settings is clearly required.
Finally, the patients’ goals for symptom relief and improved
quality of life are also important considerations in guiding
the decision to offer surgery.
CONCLUSIONS
We have developed clinical prediction rules for postoper-
ative mortality and major morbidity after GPEH repair in
a high-volume center with extensive expertise in the man-
agement of GPEH that have good discriminatory accuracy
and facilitate assignment of patients to risk categories for
adverse outcome. Our models included patient age at oper-
ation, sex, urgency of surgery, congestive heart failure, and
pulmonary disease. After further refinement and prospec-
tive validation, these clinical prediction rules for mortality
and major morbidity after GPEH repair could provide
patient-specific risk prediction, tailored for individual
patient characteristics, and contribute to decision-making
regarding surgical intervention.
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